Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Guided Therapeutics Inc. (GTHP) had Cost of Goods Sold of $0.04M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.12M |
|
$-0.86M |
|
|
Cost of Goods Sold |
$0.04M |
$0.08M |
|
$0.88M |
|
$-0.76M |
|
$-0.05M |
|
$-0.81M |
|
$-0.81M |
|
$-0.81M |
|
$-0.81M |
|
$-0.81M |
|
$-0.81M |
|
$-0.76M |
|
$-0.67M |
|
78.84M |
|
78.84M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.81M |
|
$0.02M |
|
$0.13M |
|
$0.94M |
|
$6.38M |
|
$0.04M |
|
$0.04M |
|
$6.41M |
|
$-7.65M |
|
$-5.47M |
|
$-5.47M |
|
78.97M |
|
| Cash Flow Statement Financials | |
$-0.50M |
|
$0.00M |
|
$0.30M |
|
$0.39M |
|
$0.18M |
|
$-0.20M |
|
$0.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.13 |
|
-- |
|
-- |
|
-0.01 |
|
-0.39 |
|
67.52% |
|
-652.14% |
|
-652.14% |
|
-- |
|
-693.16% |
|
-731.62% |
|
$-0.50M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.06 |
|
14.62 |
|
6.15 |
|
10.60% |
|
14.82% |
|
-86.28% |
|
14.92% |
|
$-0.07 |
|
$-0.01 |
|
$-0.01 |
|